Presenters from AAOpt26's research symposium share their findings, applications for optometric practice, and goals for future study.
|Videos|May 10, 2022
Q&A: How to start the dry eye conversation with patients
Maria Sampalis, OD, shares how she approaches starting the dry eye conversation when diagnosing her patients.
Advertisement
Maria Sampalis, OD, of Sampalis Eye Care in Cranston/Providence, Rhode Island, continues her discussion with Optometry Times®' Kassi Jackson on how she approaches starting the dry eye conversation when diagnosing her patients.
Advertisement
Related to this article
For Maria Sampalis, OD, implementing AI isn't an excuse for practice owners to replace their staff with new technology; it should instead lift the burden of certain tasks to make for more patient visits.
Walline, American Academy of Optometry president, shares this year's conference attendance numbers, clinical pearls, and what he hopes to see in 2027.
Thomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026.
Kevin Chan, OD, MS, discusses an AAOpt 2026 symposium on individualized low-dose atropine dosing for myopia and the FDA outlook ahead of the SYD-101 advisory meeting.
Raman Bhakhri, OD, FAAO, alongside Xiao Yu, OD, FAAO, discussed emerging investigational therapies for the disease during their AAOpt 2026 session.
Jamie Kuzniar, OD, FAAO, FSLS, discusses a case-based AAOpt 2026 session on scleral lens complications, fitting around cross-linking, and advice for new graduates.
Kwaku Osei, OD, PhD, FAAO, discussed patient-reported outcomes with a senofilcon C (Johnson & Johnson; Acuvue Vita), reusable lens, with the majority of wearers rating comfort, vision, and handling favorably.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia
2
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
3
FAQ: What clinicians should know as SYD-101 heads to FDA advisory committee
4
FDA approves subcutaneous Enspryng for TED
5